Share of people with HIV who receive antiretroviral therapy in Lithuania
Lithuania: Share of people with HIV who receive antiretroviral therapy was 52.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Lithuania, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
In 2024, share of people with hiv who receive antiretroviral therapy in Lithuania stood at 52.0%. That is the highest value across all 25 years on record.
That represents a change of up 8.3% on the previous year and up 271.4% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Lithuania peaked at 52.0% in 2024 and was at its lowest, 0.0%, in 2000.
Lithuania ranks 117th of 143 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Lithuania, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 2.0% | — |
| 2004 | 3.0% | +50.0% |
| 2005 | 4.0% | +33.3% |
| 2006 | 4.0% | +0.0% |
| 2007 | 5.0% | +25.0% |
| 2008 | 7.0% | +40.0% |
| 2009 | 7.0% | +0.0% |
| 2010 | 8.0% | +14.3% |
| 2011 | 10.0% | +25.0% |
| 2012 | 12.0% | +20.0% |
| 2013 | 18.0% | +50.0% |
| 2014 | 14.0% | -22.2% |
| 2015 | 22.0% | +57.1% |
| 2016 | 25.0% | +13.6% |
| 2017 | 29.0% | +16.0% |
| 2018 | 38.0% | +31.0% |
| 2019 | 40.0% | +5.3% |
| 2020 | 39.0% | -2.5% |
| 2021 | 39.0% | +0.0% |
| 2022 | 44.0% | +12.8% |
| 2023 | 48.0% | +9.1% |
| 2024 | 52.0% | +8.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.2% | 0.0% | 7.0% | 10 |
| 2010s | 21.6% | 8.0% | 40.0% | 10 |
| 2020s | 44.4% | 39.0% | 52.0% | 5 |
Countries ranked near Lithuania
More health data for Lithuania
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4537 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,909 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5 deaths (2100)
- Total tetanus - number of reported cases, gaps filled 0 (2025)
- Total tetanus - number of reported cases, per capita 0 units per person (2025)
- Diphtheria - number of reported cases, gaps filled 1 (2025)
- Diphtheria - number of reported cases, per capita 0 units per person (2025)
- Measles - number of reported cases, gaps filled 11 (2025)
- Measles - number of reported cases, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Lithuania?
- Share of people with hiv who receive antiretroviral therapy in Lithuania was 52.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Lithuania?
- The highest recorded value was 52.0% in 2024.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Lithuania?
- The lowest recorded value was 0.0% in 2000.
- How does Lithuania rank for share of people with hiv who receive antiretroviral therapy?
- Lithuania ranks 117th out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Lithuania?
- Over the last ten years it is up 271.4%. The long-run trend across the full record is volatile.
- Where does this Lithuania data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.